Allogene Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Allogene TherapeuticsAllogene Therapeutics(US:ALLO) Newsfilter·2024-12-16 13:30

SOUTH SAN FRANCISCO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (NASDAQ:ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced that David Chang, M.D., Ph.D., President, Chief Executive Officer and Co-Founder of Allogene, will present at the 43rd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco. 43rd Annual J.P. Morgan Healthcare Conferen ...

Allogene Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Reportify